HomeNews Updates

MACAU’S PHARMACEUTICAL BUREAU: INFLAMMATION DRUG DIPROSPAN WITHDRAWN FROM LOCAL MARKET

<strong>MACAU’S PHARMACEUTICAL BUREAU: INFLAMMATION DRUG DIPROSPAN WITHDRAWN FROM LOCAL MARKET</strong>

WARNING: A US SAUSAGE PRODUCT MAY CONTAIN RUBBER PIECES
TOTAL 54 SUSPECTED ILLEGAL WORKERS FOUND IN 396 LOCATIONS ACROSS MACAU IN MAY 
3RD GUANGDONG-HONG KONG-MACAO GREATER BAY AREA HIGH-QUALITY TALENT DEVELOPMENT CONFERENCE TO BE HELD IN MACAU FROM 22-25 OCTOBER 

Belgium medicine Diprospan Injection 1ml batches U019788, U027875, U037539, W001030 and W026080 have been withdrawn from local market after manufacturer Schering-Plough Labo N.V. found stainless steel particles in those batches, prompting the company to recall them, Macau’s Pharmaceutical Administration Bureau (ISAF) announced recently. The bureau was notified by the drug’s local importer that has also immediately asked all medical institutions in Macau to stop using the batches. The product is a prescription drug used to treat inflammation, according to ISAF.

Photo: ISAF

COMMENTS

DISQUS: 0